Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

About

Company description

HNSP was founded in 2000 and is a publicly-traded company. We engage in development, manufacturing and marketing of both APls and drug products. We have more than 10 management members with oversea doctor degree and also oversea experience in R&D, manufacture and/or registration. HNSP enjoys a strong team of regulatory registration, and also a China-based sales force of over 400 agents. With excellent know-how in peptide chemistry, HNSP is a leader in the field of peptide manufacture in China.
Most of our facilities were built based on the EU and US CGMP standards.
HNSP has been inspected respectively by USFDA and (Italy) AIFA and the GMP status was considered acceptable and spoken highly of.
Our Thymalfasin API and FDF has also been approved by (Italy) AIFA.We are open to discuss any forms of collaborations.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer
Affiliated categories: Peptides |Finished Dosage Forms More

Recently at

24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 111D72 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Contact information

Address

Telephone

Website

View all contact information